Investors eagerly await flow tests from Austin drilling program

Published 14-SEP-2016 15:50 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

There may be some positive news on the horizon for Austin Exploration (ASX: AKK) with a high impact deviated drilling program on the Columbus #1 well to commence in coming days.

As a backdrop, AKK is an oil and gas company with a portfolio of assets in the United States. The group has a major presence in two of America’s most prolific oil and gas basins, controlling more than 15,000 acres in Colorado in a region known as the DJ Basin.

The company also controls 4000 acres in the Illinois Basin in Kentucky.

Importantly, the company is both explorer and producer with interests in producing oil and gas wells in Colorado, Kentucky and Texas.

Focusing specifically on upcoming developments at Columbus #1, management said on Wednesday that drilling of Pierre formation already showed evidence of hydrocarbons and intense natural fracture zones.

This is consistent with 3D seismic data that has demonstrated a major fracture network capable of holding significant oil reserves. It is also significant that this development has been confirmed by an independent on-site geologist.

As Austin begins to flow test three wells after completion of drilling at Columbus #1 there is potential for market moving news to be released.

What this news may be and when it is released is speculative at this stage, so if considering this stock for your portfolio seek professional financial advice.

The commencement of Columbus #1 is part of a back-to-back drilling program also involving the Magellan #1 and Marco Polo #1 wells with drilling having been completed at the latter two sites.

Management highlighted that its strategy in terms of undertaking a multi well program was designed to significantly reduce drilling costs and maximise operational efficiencies.

AKK is now well progressed with its three-phase three well program with the first stage of sequentially drilling the upper vertical sections of the three wells successfully completed.

Phase 2 is also underway, and this involves sequentially drilling the deviated wellbore sections of the three wells.

The third and final phase is to sequentially flow test the three wells. While management hasn’t provided a timeline regarding results of flow testing there is the potential for share price catalysts to emerge.

AKK is a relatively small player operating in the high risk oil and gas exploration space and as such it represents a speculative investment with no surety regarding the outcome of drilling initiatives. As such, investment decisions should not be based on information contained in this article.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free